Fluoresentric has appointed Lynda Merrill as CEO, replacing previous CEO William Olson. Merrill is currently a board member of Fluoresentric subsidiary XCR Diagnostics, a position she will continue to hold. She has also held senior management positions at Qiagen, Boehringer Mannheim, Gen-Probe, and Immunodiagnostic Systems.
HealthTell, a company developing diagnostic, prognostic, and monitoring tests for complex immune-mediated diseases, has named Bob Barrett as vice president of marketing and commercial operations. Barrett has held executive commercial positions at companies including Chiron, Roche, Qiagen, and Applied Biosystems/Life Technologies.
Sygnis has appointed Heikki Lanckriet as co-CEO and CSO, the latter being a newly created position at the company. Lanckriet is currently CEO of Expedeon Holdings, which he co-founded in 2003, and where he has served as CSO and Chief Operating Officer. Lanckriet will also become a member of Sygnis' management board along with Pilar de la Huerta, who will serve as co-CEO and CFO of the company.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.